Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
IMPACT: Improving Access to Cancer Survivorship Via Telehealth
5 other identifiers
interventional
261
1 country
1
Brief Summary
This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care plan created by the patient (self-generated) may help them to better transition from oncology to primary care and improve communication between care teams in order to meet these needs and create better health outcomes. Telehealth is a way of delivering health care services from a distance, including patient education. Combining a self-generated survivorship care plan with telehealth education may help to improve knowledge and self-efficacy in cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2019
CompletedFirst Posted
Study publicly available on registry
September 9, 2019
CompletedStudy Start
First participant enrolled
February 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedApril 8, 2026
April 1, 2026
5.9 years
August 29, 2019
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Initial participation rate of cancer survivors identified from community-based or partner practices, and Cancer Surveillance System of Western Washington
Up to 8 weeks
Accuracy of survivors' self-generated survivorship care plans (SCPs) in relation to those based on medical record abstraction
Will measure the accuracy of participants' SCPs by comparing their self-reported medical history collected via questionnaire, with data abstracted from medical records. Accuracy will be reported by percentage of missing data in the self-generated SCP compared to medical records, and percentage of incorrect data in the self-generated SCP compared to medical records.
Up to 8 weeks
Proportion of survivors who receive the phone-based education session within the study time period
Up to 8 weeks
Proportion of survivors who complete the follow-up questionnaire within the study time period
Up to 8 weeks
Response rate among primary care providers (PCPs) to the PCP survey
Up to 8 weeks
Secondary Outcomes (4)
Participant perceived self-efficacy: questionnaire using the PROMIS Global 10 and health related self-efficacy scales
Up to 8 weeks
Survivorship knowledge
Up to 8 weeks
PCP self-efficacy towards survivorship care
Up to 8 weeks
Local oncology clinics' attitudes towards survivorship care implementation
Up to 8 weeks
Study Arms (5)
Arm I (patient-generated SCP)
ACTIVE COMPARATORPatients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).
Arm II (patient-generated SCP, counseling)
EXPERIMENTALPatients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.
Arm III (generic information)
ACTIVE COMPARATORPatients receive generic information on survivorship care on study.
Arm IV (generic information, patient-generated SCP)
ACTIVE COMPARATORPatients receive generic information on survivorship care and a self-generated SCP as in Arm I on study.
Arm V (generic information, patient-generated SCP, counseling)
EXPERIMENTALPatients receive generic information on survivorship care as well as a self-generated SCP as in Arm I and a telephone-based educational counseling session as in Arm II on study.
Interventions
Receive patient-generated SCP
Receive telephone-based educational counseling session
Ancillary studies
Receive generic information on survivorship care
Eligibility Criteria
You may qualify if:
- Cancer survivors who have completed curative therapy within the past 5 years (may still currently be on long-term/targeted non-cytotoxic agent maintenance therapy, e.g., tamoxifen or aromatase inhibitors for breast cancer survivors; androgen deprivation therapy for prostate cancer survivors)
- History of either adult-onset (age \>= 18) lymphoma, breast, colorectal, lung, or prostate cancer
- Able to perform all study requirements, including responding to questionnaires
- Willing to be randomized
- Capable of providing informed consent
- Consent to release oncology and primary care medical records
- English or Spanish speakers
- PRIMARY CARE PROVIDERS: PCPs responsible for delivering primary care to IMPACT study participants will be contacted about participating in the study after participant enrollment into the study.
- ONCOLOGY STAFF: Oncology Staff (Oncologists, Nurse Practitioners, Physician's assistants) will be recruited from sites involved in the IMPACT study
- CLINIC ADMINISTRATORS: Clinic administrators will be recruited from sites involved in the IMPACT study
You may not qualify if:
- Currently on palliative or hospice care, or considering transferring to such care within the next 3 months
- Lacks telephone access
- Lacks mailing address or ability to receive study materials electronically
- Currently being followed in a pediatric clinical setting (either for primary care or for cancer care)
- History of having had \> 1 cancer type diagnosed and treated (exception is for skin cancers treated with surgical excision alone; also, individuals who only have had relapse of their initial cancer remain eligible so long as they have completed curative therapy and meet all other eligibility criteria)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fred Hutchinson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Related Publications (3)
Yi JC, Lee E, Duggan C, Baker KS, Blythe N, Cole AM, Cushing-Haugen KL, Gutierrez AI, Linden H, Mendoza JA, Ohlsen TJD, Ortblad KF, Schwartz SM, Yung R, Ceballos R, Chow EJ. Perspective of Hispanic Cancer Survivors on Survivorship Care Plans: A Qualitative Study. J Immigr Minor Health. 2025 Oct 14. doi: 10.1007/s10903-025-01794-8. Online ahead of print.
PMID: 41087806DERIVEDChow EJ, Blythe NA, Cushing-Haugen KL, Duggan C, Baker KS, Cole AM, Green S, Guiterrez AI, Lee E, Linden HM, Mendoza JA, Ohlsen TJD, Ortblad KF, Schwartz SM, Yung RL, Ceballos RM. Enhancing survivorship care among Hispanic/Latino cancer survivors via lay health educators: results of a pilot randomized trial. J Cancer Surviv. 2025 Feb 15:10.1007/s11764-025-01758-9. doi: 10.1007/s11764-025-01758-9. Online ahead of print.
PMID: 39955465DERIVEDDuggan C, Cushing-Haugen KL, Cole AM, Allen J, Gilles R, Hornecker JR, Gutierrez AI, Warner J, Baker KS, Ceballos RM, Chow EJ. Feasibility of delivering survivorship care via lay health educators: A pilot randomized controlled trial among rural cancer survivors. J Rural Health. 2023 Jun;39(3):666-675. doi: 10.1111/jrh.12736. Epub 2023 Jan 2.
PMID: 36593127DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Chow
Fred Hutch/University of Washington Cancer Consortium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Masking Details
- Personnel other than the statisticians and lay health educators
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2019
First Posted
September 9, 2019
Study Start
February 19, 2020
Primary Completion
December 31, 2025
Study Completion
March 31, 2026
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share